What did @peptidepouches actually say?
The creator described taking powder from a GHK-Cu peptide bottle and loading it into what appear to be oral pouches, similar in format to nicotine or caffeine pouches. They said the product is "coming out next month." That is the full extent of the claim. There is no efficacy talk, no dosing guidance, no disease treatment promise. It is essentially a product teaser.
To be fair, there is not much to fact-check in the literal transcript. The claim is: we are reformatting a peptide powder into a pouch delivery system. Whether that is scientifically sound, legally defensible, and safe is where things get interesting, because the format itself raises real questions that a half-million viewers probably did not think to ask.
Does the science back this up?
The peptide shown is almost certainly GHK-Cu, a copper-binding tripeptide with a genuinely interesting research profile. The delivery format, however, is the problem. GHK-Cu has been studied primarily in topical and injectable forms. Oral bioavailability for peptides in general is notoriously poor.
Peptides are chains of amino acids. The digestive system is specifically designed to break them apart. Enzymes in saliva and the gastrointestinal tract cleave peptide bonds before most compounds reach systemic circulation. A sublingual or buccal pouch could theoretically bypass some of that digestion by absorbing through oral mucosa, but GHK-Cu specifically has not been validated for this route in peer-reviewed human trials.
Pickart and Margolina (2018, Cosmetics) reviewed GHK-Cu's biological activity extensively, but their work focused on topical skin applications and in vitro models. Abdulghani et al. (2021, Journal of Drugs in Dermatology) similarly examined GHK-Cu in wound healing contexts, again via topical application. No published human pharmacokinetic data exists confirming that a buccal pouch format delivers meaningful systemic concentrations of this peptide.
What did they get wrong (or right)?
The creator did not make false efficacy claims, which is more restraint than most peptide influencers show. Credit where it is due. They did not say GHK-Cu heals wounds, reverses aging, or treats any condition. They showed a product format and announced a launch date.
What they glossed over entirely is that reformulating a research peptide into a consumer pouch product and selling it is not a trivial regulatory step. Peptides like GHK-Cu are not FDA-approved drugs for systemic use. Depending on claims made at launch, this product could be classified as a dietary supplement, a drug, or an unapproved new drug. The FDA has repeatedly sent warning letters to companies selling peptides as supplements when implied disease treatment claims appear in marketing materials.
The buccal delivery angle is also unproven for this compound specifically. Assuming that what works in a nicotine pouch or a melatonin strip translates cleanly to a copper-binding peptide is not supported by available evidence. That assumption could mean the product simply does not work as intended, which is the most charitable outcome.
What should you actually know?
If you are considering buying this product when it launches, here is what the video did not tell you. First, GHK-Cu's most replicated benefits, collagen synthesis stimulation and antioxidant gene expression, come from topical application directly to tissue. Pickart's foundational work established this in skin models, not in oral delivery systems.
Second, the regulatory status of this product format is genuinely unclear. A peptide powder in a pouch sold to consumers sits in a gray zone that the FDA has been actively narrowing since 2023, when the agency formally excluded certain peptides from the dietary supplement category.
Third, copper itself has a narrow therapeutic window. GHK-Cu contains copper in a chelated form, but regular buccal dosing of copper-containing compounds without clinical oversight is not something that has a clean safety record in humans at meaningful doses. The National Institutes of Health Office of Dietary Supplements flags copper toxicity as a real concern above 10mg daily.
None of this means the product will be dangerous or ineffective. It means the burden of proof is on the manufacturer to show bioavailability, safety, and legal compliance before those pouches ship in May.